CoChat

Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathway

Abdel-latif, Rania G., Rifaai, Rehab A., Amin, Entesar F. · 2020 · Archives of Pharmacal Research

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

Ischemic stroke is a serious condition associated with severe functional disability and high mortality, however; effective therapy remains elusive. Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, has been shown to exert additional non-glycemic benefits including anti-apoptotic effects in different disease settings. Thereby, this study was designed to investigate the ameliorative effect of empagliflozin on the neuronal apoptosis exhibited in cerebral ischemia/reperfusion (I/R) in a rat model targeting HIF-1α/VEGF signaling which is involved in this insult. Global cerebral I/R injury was induced in male Wistar rats through occlusion of the bilateral common carotid arteries for 30 min followed by one-hour reperfusion. Empagliflozin doses of 1 and 10 mg/kg were administered 1 and 24 h after reperfusion. In I/R-injured rats, empagliflozin treatments significantly reduced infarct size and enhanced neurobehavioral functions in a dose-dependent manner. The drug alleviated neuronal death and cerebral injury inflicted by global ischemia as it suppressed neuronal caspase-3 protein expression. In parallel, protein expressions of HIF-1α and its downstream mediator VEGF were upregulated in the ischemic brain following empagliflozin treatment. The results indicated that empagliflozin attenuates cerebral I/R-induced neuronal death via the HIF-1α/VEGF cascade.

Overview

Integrity signals

Registry

Crossref · 10.1007/s12272-020-01237-y

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 63 references

Research works printed but not linked: 1

  1. Zapata-Morales JR, Galicia-Cruz OG, Franco M, y Morales FM (2014) Hypoxia-inducible factor-1α (HIF-1α) protein diminishes sodium glucose transport 1 (SGLT1) and SGLT2 protein expression in renal epithelial tubular cells (LLC-PK1) under hypoxia. J Biol Chem 289:346–357. https://doi.org/10.1074/jbc.M113.526814 · DOI

Cited by

See all 92

Metadata

Authors
Abdel-latif, R. G., Rifaai, R. A., & Amin, E. F.
Affiliations
Minia University (EG)
Venue
Archives of Pharmacal Research
Published
2020-05
Volume
43
Issue
5
Pages
514-525
ISSN
  • 0253-6269 (ISSN-L)
  • 1976-3786
OpenAlex
W3027004825
Cited by
92
References
62
Citations by year
2026: 10 · 2025: 18 · 2024: 20 · 2023: 15 · 2022: 16 · 2021: 12 · 2020: 1
FWCI
4.28
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Archives of Pharmacal Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords
empagliflozin, cerebral ischemia-reperfusion injury, neuronal apoptosis, HIF-1α, vascular endothelial growth factor, ischemic stroke, SGLT2 inhibitors, caspase-3, infarct size, neurobehavioral function, global cerebral ischemia
MeSH terms
Administration, Oral, Animals, Benzhydryl Compounds, Brain Ischemia, Disease Models, Animal, Glucosides, Male, Signal Transduction, Reperfusion Injury, Rats, Wistar, Apoptosis, Vascular Endothelial Growth Factors, Rats, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathway. https://app.cochat.ai/papers/10.1007/s12272-020-01237-y
The paper
Abdel-latif, R. G., Rifaai, R. A., & Amin, E. F. (2020). Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathway. Archives of Pharmacal Research. https://doi.org/10.1007/s12272-020-01237-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.